GF
ITRM

GGM Financials’s Iterum Therapeutics ITRM Stock Holding History

GGM Financials’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$1 – 228
2025
Q3 		$1 Buy
+1
New +$1 ﹤0.01% 224

Other funds holding ITRM

AF
Apollon Financial Mount Pleasant, South Carolina $848M AUM 27.31% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $213M AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

GGM Financials's ITRM Position: Q4 2025 in Review

GGM Financials sold out of Iterum Therapeutics (ITRM) in Q4 2025, closing a stake of 1 share — an estimated $1 sold.

GGM Financials first reported a position in ITRM in Q3 2025 and held it in 1 quarter. The position peaked at $1 in Q3 2025. 20 funds tracked by Wall St. Rank hold ITRM as of Q4 2025.

  • GGM Financials reported no remaining Iterum Therapeutics position as of Q4 2025 after selling out during the quarter.
  • GGM Financials sold 1 Iterum Therapeutics share in Q4 2025, an estimated $1.
  • GGM Financials first reported a position in Iterum Therapeutics in Q3 2025 and held it in 1 quarter.
  • GGM Financials's Iterum Therapeutics position peaked at $1 in Q3 2025.
  • 20 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q4 2025.

Based on GGM Financials's 13F filing for Q4 2025, filed 4 Feb 2026.